IsoPSA test for prostate cancer

madman

Super Moderator

The non-invasive IsoPSA blood test assesses high-grade prostate cancer likelihood before or after a biopsy. Recently included in National Comprehensive Cancer Network guidelines for early detection. A real-world study on 734 patients aged 50+ with PSA levels between 4-100 ng/mL and no history of prostate cancer showed a 55% reduction in biopsy recommendations and a 9% reduction in MRI imaging with IsoPSA. High concordance between physician recommendations and IsoPSA results. IsoPSA has FDA Breakthrough Therapy designation and awaits FDA premarket approval.
 
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

Online statistics

Members online
1
Guests online
270
Total visitors
271

Latest posts

Back
Top